Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,185 | 5,455 | 2,721 | 1,424 | 3,906 |
| Marketable Securities | N/A | N/A | N/A | N/A | 184 |
| Receivables | 2,190 | 641 | 610 | 750 | 549 |
| Other current assets | 4,755 | 1,069 | 0 | 0 | 0 |
| TOTAL | $14,872 | $7,918 | $4,229 | $2,798 | $5,227 |
| Non-Current Assets | |||||
| PPE Net | 3,400 | 3,237 | 3,783 | 4,255 | 3,638 |
| Intangibles | 1,213 | 1,339 | 1,844 | 2,081 | 2,286 |
| Other Non-Current Assets | 2,783 | 2,963 | 2,800 | 2,513 | 1,974 |
| TOTAL | $7,396 | $7,539 | $8,427 | $8,849 | $7,898 |
| Total Assets | $22,268 | $15,457 | $12,656 | $11,647 | $13,125 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,176 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 617 | 553 | 549 | 528 | 423 |
| Accrued Expenses | 1,718 | 1,307 | 1,136 | 1,558 | 1,079 |
| Other current liabilities | 481 | 237 | 367 | 192 | 74 |
| TOTAL | $7,093 | $3,608 | $3,388 | $3,868 | $3,336 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,143 | 962 | 29 | N/A | N/A |
| Deferred Revenues | 1,836 | 593 | 919 | 463 | 520 |
| Other Non-Current Liabilities | 7 | 0 | 141 | 323 | 99 |
| TOTAL | $4,251 | $2,647 | $1,374 | $1,429 | $328 |
| Total Liabilities | $11,344 | $6,255 | $4,762 | $5,297 | $3,664 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 2 | 2 | 2 |
| Common Shares | 462 | 393 | 355 | 305 | 304 |
| Retained earnings | -117,845 | -112,799 | -111,730 | -110,719 | -107,284 |
| Other shareholders' equity | 24 | 176 | 313 | 267 | 327 |
| TOTAL | $10,924 | $9,202 | $7,894 | $6,350 | $9,461 |
| Total Liabilities And Equity | $22,268 | $15,457 | $12,656 | $11,647 | $13,125 |